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Poliovirus-infected cells contain a previously unrecognized particle which
appears to be an intermediate in virion synthesis and therefore has been named
proviron. It sediments at about 125S, contains the three procapsid proteins,
VP-O, VP-1, and VP-3, and has 35S viral RNA. It is disrupted both by sodium
dodecyl sulfate and EDTA but the RNA resists digestion by ribonuclease. Pulse-
chase experiments and studies employing the virus-specific inhibitor, guanidine,
all indicate that the proviron is formed by combination of newly made RNA with
the procapsid. Cleavage of VP-0 to form VP-2 and VP-4 follows formation of the
provirion and would be the final step in poliovirus morphogenesis.
Poliovirus morphogenesis involves a series of
steps in which the capsid proteins are processed
by proteolysis and are aggregated into struc-
tures of increasing size (3). The capsid proteins
are translated from the viral genome into a
single polypeptide, called NCVP 1 (14, 22). This
polypeptide is cleaved to generate three pro-
teins: VP-0, VP-1, and VP-3 (11, 13, 15, 21).
Units of increasing complexity consisting of
equimolar amounts of these three proteins are
then assembled and combined with RNA to
form the finished virion.
We have previously presented evidence that
the protein complex to which RNA is added is a
completed shell called the procapsid which
sediments at about 80S (15). The latter stages of
morphogenesis involve both union of the RNA
and protein and a final proteolytic cleavage in
which the VP-0 is split into VP-2 plus VP-4. The
mature virion sediments at about 155S.
The present investigation is concerned with
the isolation of a new poliovirus-specific ribonu-
cleoprotein particle which appears to be a new
intermediate in the pathway of poliovirus mor-
phogenesis and which appears to be the imme-
diate precursor of the virion. It consists of the
procapsid proteins plus viral RNA and we have
provisionally named it the provirion to denote
its apparent role as the progenitor of the virion.
MATERIALS AND METHODS
The growth of suspended HeLa cells, their infection
by type 1 poliovirus in the presence of 5 ,g of
actinomycin D per ml, and the analysis of virus-
related particles by means of sucrose gradient centrif-
ugation have been previously described (5, 15). For
analysis by polyacrylamide gel electrophoresis, puri-
fied virus and virus-related particles were disrupted
by boiling for 5 min in a solution of 1% mercaptoetha-
nol, 1% sodium dodecyl sulfate (SDS), and 15%
glycerol. The solutions were then subjected to the
Maizel and Laemmli modification of polyacrylamide
gel electrophoresis (C. N. Cole and D. Baltimore, J.
Mol. Biol., vol. 76, in press; 18, 19).
3H-leucine (39 Ci/mmol), 14C-leucine (260 mCi/
mmol), 3H-uridine (40 to 50 Ci/mmol), and '4C-uri-
dine (50 mCi/mmol) were obtained from New Eng-
land Nuclear Corp.
RESULTS
Identification of the provirion. HeLa cells
infected for 3 h with poliovirus were labeled for
30 min with 3H-leucine and for 15 min with
14C-uridine. Analysis of detergent-treated cyto-
plasmic extracts of these cells by sedimentation
through a sucrose gradient revealed a number of
different virus-related structures (Fig. 1). 3H-
leucine was recovered in virions (155S), procap-
sid (80S), and low molecular weight material.
"4C-uridine was incorporated into virions, viral
ribonucleoprotein (87S) (6), and lower molecu-
lar weight material. Both labels also appeared
in a structure not previously recognized which
sedimented at about 125S. We call this struc-
ture the provirion, a designation we will justify
by the evidence presented below.
Components of the provirion. The protein
content of the provirion, labeled with radioac-
tive leucine, was analyzed by polyacrylamide
gel electrophoresis in the presence of SDS.
Electrophoresis of provirion proteins mixed
with either proteins of virion or procapsid (Fig.
2) showed that provirion contained the same
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FIG. 1. Sucrose density gradient analysis of cytoplasmic extracts. At 3 h after infection, 4 x 107 cells were
transferred to Earle saline (8), supplemented with 3H-leucine (20 uCi/m)); at 3 h 15 min, 14C-uridine (1 gCi/ml)
was added; at 3 h 30 min, the cells were harvested by centrifugation and transferred to complete medium
supplemented with 100-fold the normal concentration of leucine, and 5 min later a cytoplasmic extract in RSB
(0.01 M Tris, pH 7.4; 0.01 M NaCI; 0.0015 M MgCI2) was prepared. To the extract was added 1% sodium
deoxycholate and 1% BRIJ-58 and it was layered onto a linear 15 to 30% sucrose-RSB gradient and centrifuged
at 95,000 x g for 4 h in theSW 27 rotor at 4 C. A260 and radioactivity were determined in fractions from the
gradients as described previously (5). Arrows indicate the position of virion (V), provirion (PV), procapsid (PC),
and viral ribonucleoprotein (vRNP).
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FIG. 2. Polyacrylamide gel electrophoresis of provirion proteins. Cells infected for 3 h were labeled with
3H-leucine or 14C-leucine for 30 min and cytoplasmic extracts were prepared and fractionated as described in
Fig. 1. Samples of poliovirion, provirion, and procapsid were prepared for electrophoresis and analyzed on 10%
acrylamide-ethylene diacrylate gels at 100 V for 6 h. After electrophoresis, gels were removed from tubes, sliced,
and radioactivity was assayed (C. N. Cole and D. Baltimore, J. Mol. Biol., in press). a, '4C-leucine-labeled
virion and 3H-leucine-labeled provirion. b, 3H-leucine-labeled procapsid and 'C-leucine-labeled provirion.
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proteins as procapsid (VP-0, VP-1, VP-3) and
was lacking the virion protein, VP-2.
The RNA of provirion was analyzed by su-
crose gradient velocity sedimentation iFi the
presence of a differentially labeled preparation
of virion RNA (Fig. 3), Most of the provirion
RNA sedimented indistinguishably from virion
RNA.
Propprties or the provirion. The stability of
lebeled provirion to various tr6atnients was
studied in order to provide an indication of the
structure of the particle. When ;an extract of
cells labeled with both uridine and leucine was
treated with ribonuclease, the provirion was
found to be stable to the enzyme (Fig. 4),
indicating that the RNA of the particle is
protected by the protein. (In this experiment,
the peak of ribonuclease-resistant RNA at frac-
tion 20 of Fig. 4B was presumably double-
stranded RNA, much of which would arise from
the replicative intermediate RNA, ref. 4.)
Treatment of the isolated provirion with SDS
caused its disruption (Fig. 5); as is evident in
Fig. 5 and from previous studies (20), the virion
is SDS-resistant. Treatment of the provirion
with EDTA also disrupted it and liberated
separated procapsid and viral RNA (Fig. 6).
The virion is resistant to,EDTA as evidenced by
the small remaining peak of labeled virion in
Fig. 6. The provirion is therefore a more labile
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structure than the virion, and divalent cations
are important for maintaining its structure.
Provirion as precursor of virion. In order to
investigate whether the provirion might be a
precursor of the virion, a number of approaches
were used. First of ill, the labeling of procapsid
a9yd provirion in the presence of guanidine was
studied. Guanidline is able to inhibit the pro-
duction of any new viral RNA which can act as
precursor to virion RNA (1, 2, 12) and if
provirion is on the pathway of virion produc-
tion, one would expect that guanidine would
inhibit its production. As seen in Fig. 7, cells
labeled with 3H1-leucine in the presence of
guanidine and maintained in guanidine-con-
taining medium did tiot synthesize any provi-
rion although, in agreement with previous re-
sults (15), they did synthesize procapsid.
A second approach to the analysis of the role
of provirion was a study of the kinetics of
labeling of procapsid, provirion, and virion
under conditions where virions were being pro-
duced. The experiment was performed by label-
ing cells with 3H-leucine in the presence of
guanidine and then both adding an excess of
unlabeled leucine and removing the guanidine.
Figure 8a to e shows sucrose gradient profiles of
samples taken at various times after exposure of
cells to 3H-leucine. In the early samples, peaks
of both provirion and virion of approximately
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FIG. 3. Comparison of the sedimentation rates of virion and provirion RNA in sucrose SDS gradients.
Labeled RNA was extracted by the acetic acid-SDS method (10, 20), mixed with unlabeled HeLa cell ribosomal
RNA, layered over a 35-ml linear 15 to 30% sucrose-SDS gradient, and sedimented for 15 h at 95,000 x g in the
SW-27 rotor at 22 C. Fractions of 1 ml were collected and analyzed for both A,280 and radioactivity. Symbols: A,
14C-uridine virion; 0, 3H-uridine provirion.
1124 J. VIROL.
MORPHOGENESIS OF POLIOVIRUS. II
I
1
x
E3)
c)
-j
CL
E
I,
to
to
11
ci)
C
._
D
4-,
N _
0
x
_
E
tn4-O0
5 10 15 20 25 30
Fraction Number
FIG. 4. Effect of ribonuclease on the provirion. At 3 h 30 min after infection, a cytoplasmic extract was
prepared from 4 x 107 cells labeled with "4C-uridine (1 uCi/ml) for 15 min and 3H-leucine (20 ,Ci/ml) for 30 min.
It was adjusted to 0.3M NaCl, 0.03M Na citrate, and half was exposed to pancreatic ribonuclease A (10 pg/ml)
for 5 min at 37 C. Samples were analyzed on 15 to 30%0 sucrose gradients in 0.3M NaCl, 0.03M Na citrate, as
described in Fig. 1. a, Not exposed to ribonuclease; b, cytoplasmic extract exposed to ribonuclease.
equal height were observed. As time passed, the
amount of virion increased relative to provirion.
The quantitation of this data is shown in Fig.
8F. Here it is evident that with time the amount
of label in procapsid decreased, whereas the
amounts in both virion and provirion increased.
Initially, label in provirion increased more rap-
idly than in virion. At later times, the labeling
of provirion began to reach a plateau. These
kinetics are consistent with the provirion being
a precursor of the virion. In this experiment, the
total amount of label in the three particles
increased slightly over the period of sampling
because there was continual generation of pro-
capsid from the polypeptides labeled during the
exposure to 3H-leucine.
In a third type of experiment, cells were
exposed to 3H-leucine, and labeled virion, provi-
rion, and procapsid were allowed to form. Then
guanidine was added to the cells. Samples were
taken at various times and analyzed on sucrose
gradients. Figure 9 shows that in the period
after guanidine addition, radioactivity in provi-
rion disappeared from the sucrose gradient
pattern. Graphic representation of the data
from this experiment (Fig. 10) showed that the
decrease in radioactivity in provirion was paral-
leled by an approximately eqiual increase of
radioactivity in virion, strongly supporting the
concept that provirion is a precursor of virIon.
Radioactivity in procapsid continued to in-
crease after guanidine treatment as would be
expected from earlier results (15).
DISCUSSION
Analyses of poliovirus-infected HeLa cells
have revealed a previously undetected, virus-
specific particle sedimenting at about 125S.
This particle, which we call the provirion, is
labeled with both uridine and leucine-the
uridine is found in viral RNA molecules, the
leucine is found in the three procapsid proteins,
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FIG. 5. Disruption of provirion by SDS. Labeled cytoplasmic extracts were made as described in Fig. 4, and
provirion purified on a sucrose gradient. Fractions containing provirion were harvested; half of the sample was
made 0.5% SDS and the other half remained in RSB. Samples were layered onto a linear sucrose-RSB gradient
and analyzed as described in Fig. 1. a, Provirion not exposed to SDS; b, provirion exposed to SDS.
VP-0, VP-1, and VP-3. The provirion is less
stable than the virion to various treatments.
Like the procapsid, it is sensitive to SDS. Its
sensitivity to EDTA is its most unique charac-
teristic and may explain why it has not been
noticed previously. The RNA of the particle
resists digestion with ribonuclease, suggesting
that the RNA is interior to and protected by the
protein. Because the particle is unstable in CsCl
we have not been able to ascertain its buoyant
density.
The role of provirion as a precursor to the
virion cannot be rigorously proven by in vivo
kinetic experiments but a number of results are
consistent with such a role and very special
circumstances would have to pertain if it is not
a precursor. First, its structure is just that of
precursor-it contains viral RNA and procapsid
proteins and it needs only the final cleavage of
VP-0 to become a virion. Second, the movement
of leucine into provirion requires the concomi-
tant synthesis of viral RNA-guanidine blocks
morphogenesis at the stage of procapsid. Third,
in a pulse-chase experiment with 3H-leucine,
radioactivity accumulates in provirion before
virion and radioactivity in provirion starts to
reach a plateau while that in virions is rising.
Such behavior is what would be expected for a
precursor. Fourth, 3H-leucine-labeled provirion
disappears after guanidine addition and labeled
virions continue to appear only as long as
provirions contain radioactivity. Together,
these experiments strongly suggest that the
provirion is the direct precursor of the virion.
Probably, only in vitro experiments can prove
this assertion unambiguously.
Previous evidence indicated that the procap-
sid is the protein precursor of the virion (15).
Even though this has not been rigorously
proven, and procapsid is difficult to demonstrate
in at least one poliovirus-infected cell system
(MiO cells) (9), it is striking that treatment of
the provirion with EDTA leads to release of the
RNA with an apparently intact procapsid as the
product. Whatever the process involved in re-
lease of the RNA, its occurrence makes it easier
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FIG. 6. Effect of EDTA on the provirion. Provirion labeled with 14C-uridine and 3H-leucine was isolated as
described in Fig. 5. Half of the sample was exposed to 0.02 M EDTA and layered onto a linear 15 to 30% sucrose
gradient in 0.01 M Tris, pH 7.4, 0.01 M NaCI, 0.02 M EDTA; the other half remained in RSB and was layered
onto a linear 15 to 30% sucrose-RSB gradient. Centrifugation was in the SW27 rotor, at 95,000 x g for 4 h at
4 C. Fractions were collected and radioactivity was determined. a, Provirion in RSB; b, provirion exposed to
EDTA.
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to imagine that the provirion forms by addition
of RNA to the procapsid. Another model for this
process is the release of turnip yellow mosaic
virus RNA by urea, formamide, or interaction
with cell receptors, which also leaves an appar-
ently intact protein shell (7, 16, 17). We would
therefore interpret the available evidence as
indicating that the penultimate step in virion
maturation is association of the procapsid with
viral RNA and the final step is cleavage of VP-O
to VP-2 plus VP-4. In this final step, the particle
is converted from an SDS- and EDTA-sensitive
form to a more stable configuration. Caliguiri
and Compans (J. Gen. Virol., in press) have
demonstrated that poliovirus morphogenesis oc-
curs in association with a smooth membrane
FIG. 7. Absence of provirion synthesis in the pres-
ence of guanidine. A culture of8 x 107 infected cells in
20 ml of medium were transferred to Earle saline and
treated with guanidine (2 mM) at 3 h after infection.
3H-leucine (20 MCi/ml) was added at 3 h 15 min; at
3 h 35 min the cells were harvested by centrifugation
and resuspended in complete medium supplemented
with guanidine and 100-fold the normal concentration
of leucine; portions of 10 ml were harvested 20 and 80
min later; cytoplasmic extracts were prepared and
analyzed in sucrose-RSB gradients as described in
Fig. 1. a, At 20 min; b, at 80 min.
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FIG. 8. Appearance of virion and provirion after accumulation ofprocapsid in the presence ofguanidine. At 3
h postinfection 3.2 x 108 infected cells were exposed to guanidine (2 mM) for 15 min and then 3H-leucine (20
ACi/ml) was added. After 15 min the cells were transferred to new medium supplemented with 100-fold the
normal concentration of leucine and lacking guanidine (t = 0). At various times, 10-ml portions were harvested,
cytoplasmic extracts were prepared, and they were analyzed as described in Fig. la to e. Samples taken at 20,
30, 40, 60, and 90 min, respectively. f, Normalized amount of radioactivity in the various particles. The amount
of radioactivity in each peak was summed and the samples were normalized to the content of A2,. of 60S
ribosomal subunits. The total radioactivity in virus-specific particles was determtined by summing the
normalized values.
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FIG. 9. Disappearance ofprovirion after exposure of cells to guanidine. A culture of 2 x 108 infected cells was
exposed to guanidine (2 mM) at 3 h postinfection, 15 min later 3H-leucine was added (20 MCi/mI), and after 20
min guanidine was removed and cells were resuspended in complete medium supplemented with 100-fold excess
of leucine. At 4 h 5 min, guanidine was added (t = 0). Portions of 10 ml were harvested at various times and
cytoplasmic extracts were prepared and analyzed as described in Fig. la to d, Samples taken at 0, 5, 15, and 30
min, respectively.
8
In'
0
(6
0
cw
'0
x
E 4
0.
0
._c
1 2
In
0 10 20 30
Time (minutes)
FIG. 10. Normalized radioactivity in particles after
exposure of cells to guanidine. Radioactivity in virion,
provirion and procapsid from experiment described in
Fig. 9 were normalized to the content of A260 of 60S
ribosomal subunit as described in Fig. 8, panel f.
fraction. The viral RNA for virion formation
therefore probably comes directly from its site
of synthesis into the procapsid.
Formation of provirion can be detected in
cell-free extracts (Fernandez-Tomas, Guttman,
and Baltimore, J. Virol., 12:1181-1183). Forma-
tion of whole virions in such extracts has not yet
been detected.
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